The Present and Future of Mitochondrial-Based Therapeutics for Eye Disease
Overview
Ophthalmology
Authors
Affiliations
Mitochondria are viable therapeutic targets for a broad spectrum of ocular diseases.
Xu J, Li Y, Yao S, Jin X, Yang M, Guo Q Biomedicines. 2024; 12(9).
PMID: 39335534 PMC: 11428814. DOI: 10.3390/biomedicines12092020.
Mitochondria in Retinal Ganglion Cells: Unraveling the Metabolic Nexus and Oxidative Stress.
Yang T, Kang E, Lin P, Yu B, Wang J, Chen V Int J Mol Sci. 2024; 25(16).
PMID: 39201313 PMC: 11354650. DOI: 10.3390/ijms25168626.
Melecchi A, Amato R, Dal Monte M, Rusciano D, Bagnoli P, Cammalleri M Front Med (Lausanne). 2023; 10:1230941.
PMID: 37731716 PMC: 10508956. DOI: 10.3389/fmed.2023.1230941.
Lenin R, Koh Y, Zhang Z, Yeo Y, Parikh B, Seah I Int J Mol Sci. 2023; 24(10).
PMID: 37240109 PMC: 10217992. DOI: 10.3390/ijms24108763.
Romani A, Zauli E, Zauli G, AlMesfer S, Al-Swailem S, Voltan R Front Oncol. 2022; 12:1000677.
PMID: 36338723 PMC: 9632280. DOI: 10.3389/fonc.2022.1000677.